Rogines-Velo María Pía, Pelorosso Facundo Germán, Zold Camila Lidia, Brodsky Paula Tamara, Rothlin Rodolfo Pedro
Departamento de Farmacología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Piso 9, CP 1121, Buenos Aires, Argentina.
Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):596-604. doi: 10.1007/s00210-002-0637-8. Epub 2002 Sep 27.
Previous studies have shown that a heterogeneous 5-HT receptor population may be involved in vasoconstrictor actions of 5-HT in human umbilical vein (HUV). The aim of the present study was to evaluate whether the 5-HT(1B/1D) receptor subtype mediates contraction in this tissue. 5-HT(1B/1D)-mediated responses can be enhanced or unmasked after exposure to threshold or sub-threshold KCl concentrations. In HUV rings, when 5-HT, alpha-Me-5HT or bradykinin concentration-response curves (CRC) were generated in the presence or absence of sub-threshold concentrations of KCl, there were not significant differences between the control and the treated rings. On the other hand, sumatriptan, the classic selective 5-HT(1B/1D) receptor agonist, produced a concentration-related contraction that was potentiated in the presence of sub-threshold KCl concentration. In addition, L-694,247, the novel selective 5-HT(1B/1D) receptor agonist, displayed a concentration-dependent contraction with high potency in HUV. The presence of sub-threshold concentrations of KCl produced a marked leftward shift of its CRCs.GR-55562, a 5-HT(1B/1D)-selective antagonist, competitively blocked sumatriptan CRCs with an estimated p A(2) of 8.00 and a slope not different from unity. Likewise, SB-216641, a selective 5-HT(1B) antagonist, produced a parallel rightward shift of sumatriptan CRCs in HUV. The Schild analysis yielded a p A(2) of 9.29, with a slope not different from unity. In addition, L-694,247 contractile responses were competitively blocked by SB-216641 with an estimated p A(2) value of 9.12 and a Schild slope not different from unity. On the other hand, ketanserin behaved as a weak antagonist of L-694,247-induced responses, yielding a calculated p A(2) value of 6.40. In summary, the results obtained in this study support that the 5-HT(1B) receptor subtype is involved in vasoconstrictor responses in HUV.
先前的研究表明,异质性的5-羟色胺(5-HT)受体群体可能参与了5-HT在人脐静脉(HUV)中的血管收缩作用。本研究的目的是评估5-HT(1B/1D)受体亚型是否介导该组织的收缩。在暴露于阈浓度或亚阈浓度的氯化钾(KCl)后,5-HT(1B/1D)介导的反应可增强或显现出来。在HUV环中,当在存在或不存在亚阈浓度KCl的情况下生成5-HT、α-甲基-5-HT或缓激肽浓度-反应曲线(CRC)时,对照环和处理环之间没有显著差异。另一方面,经典的选择性5-HT(1B/1D)受体激动剂舒马曲坦产生了与浓度相关的收缩,在存在亚阈KCl浓度时增强。此外,新型选择性5-HT(1B/1D)受体激动剂L-694,247在HUV中显示出浓度依赖性收缩且效力高。亚阈浓度KCl的存在使其CRC明显向左移位。5-HT(1B/1D)选择性拮抗剂GR-55562竞争性阻断舒马曲坦的CRC,估计pA(2)为8.00,斜率与1无差异。同样,选择性5-HT(1B)拮抗剂SB-216641使HUV中舒马曲坦的CRC平行向右移位。Schild分析得出pA(2)为9.29,斜率与1无差异。此外,SB-216641竞争性阻断L-694,247的收缩反应,估计pA(2)值为9.12,Schild斜率与1无差异。另一方面,酮色林对L-694,247诱导的反应表现为弱拮抗剂,计算得出的pA(2)值为6.40。总之,本研究获得的结果支持5-HT(1B)受体亚型参与HUV中的血管收缩反应。